Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1NET 1Head & Neck 1Endocrine 1Dermatologic 1CNS 1Breast 1

Conditions

Thyroid Neoplasms 6Neuroendocrine Tumors 5Urinary Bladder Neoplasms 3Thyroid Cancer, Papillary 3Sarcoma 3Cholangiocarcinoma 3Carcinoma, Hepatocellular 3Breast Neoplasms 3Adenocarcinoma, Follicular 3Uterine Cervical Neoplasms 2Testicular Neoplasms 2Stomach Neoplasms 2Pheochromocytoma 2Paraganglioma 2Ovarian Neoplasms 2Carcinoma, Transitional Cell 2Carcinoma, Neuroendocrine 2Brain Neoplasms 2Adrenal Gland Neoplasms 2Vaginal Neoplasms 1Uveal Melanoma 1Uterine Neoplasms 1Thyroid Carcinoma, Anaplastic 1Thymus Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Solitary Fibrous Tumors 1Small Cell Lung Carcinoma 1Skin Neoplasms 1Salivary Gland Neoplasms 1Prostatic Neoplasms 1

Interventions

pentetreotide 1fludarabine phosphate 1entinostat 1Specimen Handling 1Rose Bengal 1Melphalan 1Magnetic Resonance Spectroscopy 1LY2940680 1Interleukin-13 1Fluorodeoxyglucose F18 1Cyclophosphamide 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Uveal Melanoma × Fluorodeoxyglucose F18 × Endocrine × Clear all
NCT04119024 2026-03-17

Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors

Stanford University

Phase 1 Recruiting
18 enrolled
BreastCNSDermatologicEndocrineHead & NeckNETThoracic

Adenocarcinoma of Lung, Squamous Cell Carcinoma of Head and Neck, Uveal Melanoma, Breast Neoplasms, Adenoma, Islet Cell, Melanoma, Neoplasm Metastasis, Paraganglioma, Pheochromocytoma, Thyroid Neoplasms, Adrenocortical Carcinoma, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡